DYAX Related Analyst Comments

Oct 25, 2012 10:53 AM Dyax (DYAX) a Buy on Franchise and Pipeline Optimism

Jul 20, 2012 08:24 AM Needham & Company Maintains a 'Buy' on Dyax Corp. (DYAX); Strong Kalbitor Growth Trends

Jul 28, 2011 07:23 AM Needham & Company Maintains a 'Buy' on Dyax Corp. (DYAX); Summer Brings Rising Temperatures Along with Rising Revenues

May 31, 2011 02:34 PM Needham & Company Reiterates a 'Buy' on Dyax Corp. (DYAX); Expand Current KALBITOR Commercialization Agreement to Include Latin America and Southeast Asia

Feb 24, 2011 03:28 PM UBS Maintains a 'Buy' on Dyax Corp. (DYAX); Q4: Tempering Our Kalbitor Expectations

Feb 24, 2011 08:08 AM Needham & Company Reiterates a 'Buy' on Dyax (DYAX); L-T Sales Challenges, But Growth Potential

Jan 5, 2011 08:09 AM Needham & Company Reiterates a 'Buy' on Dyax Corp. (DYAX); The Company Continues to Focus on Building the Patient Base in HAE Orphan Indication For Long-Term Revenue Generation;

Oct 28, 2010 01:39 PM UBS Maintains a 'Buy' on Dyax (DYAX); Slow, But Steady

Sep 21, 2010 08:00 AM Needham & Company Reiterates a 'Buy' on Dyax (DYAX); Company Remains Focused on Building Steadily Growing Patient Base

Jun 29, 2010 03:45 PM Global Hunter Securities Suggest Investors Acquire a Basket of Biotech Stocks

Apr 7, 2010 08:02 AM Needham & Company Reiterates a 'Buy' Rating on Dyax (DYAX); Three Building Blocks For Growth

Dec 3, 2009 03:17 PM Wedbush Reiterates an 'Outperform' on Dyax Corp. (DYAX); Lowers Fair Value Estimate

Dec 2, 2009 09:56 AM Needham Lifts Price Target on Dyax (DYAX) to $8

Jun 8, 2009 11:24 AM Wedbush Morgan Maintains a 'Buy' on Dyax (DYAX); Comments on FDA Action